National Institute of General Medical Sciences; Notice of Closed Meetings, 10058 [E9-4845]
Download as PDF
<![CDATA[
10058
Federal Register / Vol. 74, No. 44 / Monday, March 9, 2009 / Notices
Study. The iron status of all of these
subjects is well characterized, including
measurement of plasma ferritin and
soluble transferrin receptor along with
hemoglobin/hematocrit. These
laboratory values allow each subject to
be defined as (1) iron replete, (2) iron
deficient without anemia or (3) iron
deficiency anemia. The responses to
these questions will be correlated with
the laboratory test values to determine
the relationship between blood donation
0.37. Follow up Visit: 0.25; and
Estimated Total Annual Burden Hours
Requested: Baseline visit: 866. Follow
up Visit: 383. The annualized cost to
respondents is estimated at: Baseline
Visit: $15,588, Follow up Visit: $6,894
(based on $18 per hour). There are no
Capital Costs to report. There are no
Operating or Maintenance Costs to
report.
and the development of RLS and pica
and will establish its prevalence in
these populations.
Frequency of Response: Twice.
Affected Public: Individuals. Type of
Respondents: Adult blood donors. The
annual reporting burden is a follows:
Estimated Number of Respondents:
Baseline visit: 2,340. Follow up Visit:
1,530; Estimated Number of Responses
per Respondent: 1. Average Burden of
Hours per Response: Baseline Visit:
Estimated
number of responses per
respondent
Estimated
number of
respondents
Type of respondents
Average
burden hours
per response
Estimated total
annual burden
hours
requested
Blood donors at Baseline Visit ........................................................................
Blood donors at Follow-up Visit .......................................................................
2,340
1,530
1
1
0.37
0.25
866
383
Total ..........................................................................................................
........................
........................
........................
1,249
dwashington3 on PROD1PC60 with NOTICES
Request for Comments: Written
comments and/or suggestions from the
public and affected agencies should
address one or more of the following
points: (1) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the function of the agency, including
whether the information will have
practical utility; (2) Evaluate the
accuracy of the agency’s estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and (4) Minimize the burden
of the collection of information on those
who are to respond, including the use
of appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact Dr. George Nemo,
Project Officer, NHLBI, Two Rockledge
Center, Suite 10042, 6701 Rockledge
Drive, Bethesda, MD 20892–7950, or
call 301–435–0075, or e-mail your
request to nemog@nih.gov.
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60 days of the date of
this publication.
Dated: February 27, 2009.
George Nemo,
NHLBI Project Officer, NHLBI, National
Institutes of Health.
[FR Doc. E9–4836 Filed 3–6–09; 8:45 am]
BILLING CODE 4140–01–P
VerDate Nov<24>2008
15:28 Mar 06, 2009
Jkt 217001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel. Minority Biomedical Research Score
Applications.
Date: March 25–26, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, Bethesda, MD 20814.
Contact Person: John J. Laffan, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health,
Natcher Building, Room 3AN18J, Bethesda,
MD 20892, 301–594–2773,
laffanjo@mail.nih.gov.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel. Minority Biomedical Research
Support Score Applications.
Date: March 26–27, 2009.
PO 00000
Frm 00080
Fmt 4703
Sfmt 4703
Time: 10 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, Room 3AN18, 45 Center
Drive, Bethesda, MD 20892. (Virtual
Meeting).
Contact Person: Rebecca H. Johnson, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health,
Natcher Building, Room 3AN18C, Bethesda,
MD 20892, 301–594–2771,
johnsonrh@nigms.nih.gov.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel. Molecular Biology of Hemorrhagic
Shock.
Date: March 30, 2009.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, Room 3AN18, 45 Center
Drive, Bethesda, MD 20892. (Telephone
Conference Call).
Contact Person: Brian R. Pike, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3AN18, Bethesda, MD
20892, 301–594–3907, pikbr@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS)
Dated: February 27, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–4845 Filed 3–6–09; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\09MRN1.SGM
09MRN1
]]>Agencies
[Federal Register Volume 74, Number 44 (Monday, March 9, 2009)]
[Notices]
[Page 10058]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-4845]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of General Medical Sciences; Notice of Closed
Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of General Medical
Sciences Special Emphasis Panel. Minority Biomedical Research Score
Applications.
Date: March 25-26, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center,
Bethesda, MD 20814.
Contact Person: John J. Laffan, Ph.D., Scientific Review
Officer, Office of Scientific Review, National Institute of General
Medical Sciences, National Institutes of Health, Natcher Building,
Room 3AN18J, Bethesda, MD 20892, 301-594-2773,
laffanjo@mail.nih.gov.
Name of Committee: National Institute of General Medical
Sciences Special Emphasis Panel. Minority Biomedical Research
Support Score Applications.
Date: March 26-27, 2009.
Time: 10 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Natcher Building, Room
3AN18, 45 Center Drive, Bethesda, MD 20892. (Virtual Meeting).
Contact Person: Rebecca H. Johnson, Ph.D., Scientific Review
Officer, Office of Scientific Review, National Institute of General
Medical Sciences, National Institutes of Health, Natcher Building,
Room 3AN18C, Bethesda, MD 20892, 301-594-2771,
johnsonrh@nigms.nih.gov.
Name of Committee: National Institute of General Medical
Sciences Special Emphasis Panel. Molecular Biology of Hemorrhagic
Shock.
Date: March 30, 2009.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Natcher Building, Room
3AN18, 45 Center Drive, Bethesda, MD 20892. (Telephone Conference
Call).
Contact Person: Brian R. Pike, Ph.D., Scientific Review Officer,
Office of Scientific Review, National Institute of General Medical
Sciences, National Institutes of Health, 45 Center Drive, Room
3AN18, Bethesda, MD 20892, 301-594-3907, pikbr@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.375,
Minority Biomedical Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology, Physiology, and
Biological Chemistry Research; 93.862, Genetics and Developmental
Biology Research; 93.88, Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National Institutes of Health, HHS)
Dated: February 27, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-4845 Filed 3-6-09; 8:45 am]
BILLING CODE 4140-01-P
